Brief report: Clinical implications of variant ALK FISH rearrangement patterns

INTRODUCTION: Break-apart fluorescence in situ hybridization (FISH) is the FDA-approved assay for detecting anaplastic lymphoma kinase (ALK) rearrangements in non-small cell lung cancer (NSCLC), identifying patients who can gain dramatic benefit from ALK kinase inhibitors. Assay interpretation can b...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Thorac Oncol
Asıl Yazarlar: Gao, Xin, Sholl, Lynette M., Nishino, Mizuki, Heng, Jennifer, Jänne, Pasi A., Oxnard, Geoffrey R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4634010/
https://ncbi.nlm.nih.gov/pubmed/26536196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000665
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller